Komori
Other Disclosures9627AIN HOLDINGS INC.Retail

Launch of Demonstration Testing for the “Next-Generation Pharmacy Model”

AIN Pharmacy Yokohama Minami was relocated and began operating as a pilot store for the “Next-Generation Pharmacy Model,” incorporating the latest dispensing equipment and systems, optimized workflows and other features. The group plans to roll out the results of the pilot across the entire group in the future.

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Next-Generation Pharmacy Model; AIN Pharmacy Yokohama Minami
Applicable field (uses covered by this announcement)

Pharmacy operations, dispensing, patients’ experience when visiting the pharmacy, pharmacy staff’s work environment

Launch date1 September 2026 (Tuesday) (actual)
Relationship between the counterparty and the company
AIN HOLDINGS INC.9627
Relationship with the Company

A store operated by the group

Location (as indicated in this announcement)

1-22-27 Mutsuurahigashi, Kanazawa-ku, Yokohama, Kanagawa

Impact on Business Performance

The company has stated its policy of pursuing sustainable growth, but no specific earnings impact has been disclosed.

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredNext-Generation Pharmacy Model; AIN Pharmacy Yokohama Minami
Relationship with the CompanyA store operated by the group
Launch date1 September 2026 (Tuesday) (actual)
Applicable areaPharmacy operations, dispensing, patients’ experience when visiting the pharmacy, pharmacy staff’s work environment
Location1-22-27 Mutsuurahigashi, Kanazawa-ku, Yokohama, Kanagawa
Impact on Business PerformanceThe company has stated its policy of pursuing sustainable growth, but no specific earnings impact has been disclosed.
Items this document does not state (12)
CounterpartyCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historySource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To improve patients’ experience when visiting the pharmacy, create an environment in which pharmacy staff can focus on assisting patients, and make day-to-day operations easier.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Launch of Demonstration Testing for the “Next-Generation Pharmacy Model” | AIN HOLDINGS INC. (9627) timely disclosure | Komori